American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)

American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)

Download on the App Store

American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) episodes

  • Satisfactory Response With Achieving Maintenance Low-Dose Prednisone in Generalized Myasthenia Gravis

    Dr. Elie Naddaf interviews Dr. Mazen Dimachkie on his article, Satisfactory Response With Achieving Maintenance Low-Dose Prednisone in Generalized Myasthenia Gravis. To estimate the satisfactory response rate (SR%) with achieving maintenance, low-dose prednisone in acetylcholine receptor antibody-positive generalized myasthenia gravis. In this retrospective study, we estimate the SR% as defined by (remission/minimal manifestations status for at least 6 months using 7.5 mg or less of prednisone daily, for maintenance treatment at 2, 4, and 6 years after symptoms onset) for patients who were not taking steroid-sparing immunosuppressant (SSI) as a primary outcome and for patients taking an SSI as a secondary outcome. Forty-five patients were not taking an SSI at 2 years, 34 patients at 4 years, and 17 patients at 6 years; SR% was 44.4%, 64.7%, and 58.8%, respectively. Thirty-six patients were taking an SSI at 2 years, 22 patients at 4 years, and 15 patients at 6 years; the SR% was 50.0%, 45.4%, and 66.7%, respectively. Nearly half of the generalized myasthenia gravis patients who were not taking an SSI achieved an SR.

    25 min
  • Satisfactory Response With Achieving Maintenance Low-Dose Prednisone in Generalized Myasthenia Gravis.
    Dr. Elie Naddaf interviews Dr. Mazen Dimachkie on his article, Satisfactory Response With Achieving Maintenance Low-Dose Prednisone in Generalized Myasthenia Gravis. To estimate the satisfactory response rate (SR%) with achieving maintenance, low-dose prednisone in acetylcholine receptor antibody-positive generalized myasthenia gravis. In this retrospective study, we estimate the SR% as defined by (remission/minimal manifestations status for at least 6 months using 7.5 mg or less of prednisone daily, for maintenance treatment at 2, 4, and 6 years after symptoms onset) for patients who were not taking steroid-sparing immunosuppressant (SSI) as a primary outcome and for patients taking an SSI as a secondary outcome. Forty-five patients were not taking an SSI at 2 years, 34 patients at 4 years, and 17 patients at 6 years; SR% was 44.4%, 64.7%, and 58.8%, respectively. Thirty-six patients were taking an SSI at 2 years, 22 patients at 4 years, and 15 patients at 6 years; the SR% was 50.0%, 45.4%, and 66.7%, respectively. Nearly half of the generalized myasthenia gravis patients who were not taking an SSI achieved an SR.
    25 min
  • Clinical and Electrodiagnostic Features Of Nontraumatic Sciatic Neuropathy

    Dr. Justin Willer interviews Dr. Yuebing Li about his article, Clinical and Electrodiagnostic Features Of Nontraumatic Sciatic Neuropathy. This study sought to characterize etiologies and features of sciatic neuropathy unrelated to penetrating nerve trauma. Methods: This investigation was a retrospective review of 109 patients with electrodiagnostically confirmed sciatic neuropathies. Results: Hip replacement surgery represented the most common (34.9%) etiology, whereas inflammatory sciatic neuropathy was seen in 7.3%. Electrodiagnostic testing revealed an axonal neuropathy in 95.4% and a demyelinating neuropathy in 4.6%. Predominant involvement of the peroneal division was seen in 39.4% and was tibial in 5.5%. Nine of 31 (29.0%) patients who had MRI or neuromuscular ultrasound study showed abnormalities within the sciatic nerve. At the final visit, 46.4% of patients required assistance for ambulation. Young age, lack of severe initial weakness, and presence of tibial compound muscle action potential or sural sensory nerve action potential were predictors of favorable outcome. Discussion: Sciatic neuropathies are usually axonal on electrodiagnostic testing, affect preferentially the peroneal division, and are commonly associated with incomplete recovery. Muscle Nerve 59:309–314, 2019.

    18 min

About American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)

From the publisher's feed

Hear from a variety of experts on all things neuromuscular & electrodiagnostic medicine. Learn new science, hear expert perspectives, and join the conversation!

More shows like American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)

The Art of Manliness by The Art of Manliness

The Art of Manliness

14,265 Listeners

Neurology® Podcast by American Academy of Neurology

Neurology® Podcast

296 Listeners

Practical Neurology Podcast by BMJ Group

Practical Neurology Podcast

50 Listeners

The Curbsiders Internal Medicine Podcast by The Curbsiders Internal Medicine Podcast

The Curbsiders Internal Medicine Podcast

3,336 Listeners

Bold Names by The Wall Street Journal

Bold Names

1,424 Listeners

The Peter Attia Drive by Peter Attia, MD

The Peter Attia Drive

7,915 Listeners

Neurology Minute by American Academy of Neurology

Neurology Minute

135 Listeners

Neurology Exam Prep Podcast by Neurology Exam Prep Podcast

Neurology Exam Prep Podcast

187 Listeners

Chasing Life with Dr. Sanjay Gupta by CNN Podcasts

Chasing Life with Dr. Sanjay Gupta

8,126 Listeners

The Medbullets Step 2 & 3 Podcast by Medbullets

The Medbullets Step 2 & 3 Podcast

112 Listeners

The Curious Clinicians by The Curious Clinicians

The Curious Clinicians

372 Listeners

Neurology @Point of Care Podcasts by @Point of Care

Neurology @Point of Care Podcasts

10 Listeners

The Dr. Gabrielle Lyon Show by Dr. Gabrielle Lyon

The Dr. Gabrielle Lyon Show

1,216 Listeners

Continuum Audio by American Academy of Neurology

Continuum Audio

83 Listeners

Your Brain On by Drs. Ayesha and Dean Sherzai

Your Brain On

322 Listeners